EnCor Biotechnology

EnCor Biotechnology is a biotechnology company that specializes in the development and production of antibodies and proteins for use in research, diagnostics, and therapeutics. The company is known for its innovative approaches to protein engineering and antibody production, and has a strong focus on neuroscience and neurodegenerative diseases.

History

EnCor Biotechnology was founded in the late 1990s by a group of scientists with a shared interest in understanding and treating neurodegenerative diseases. The company has since grown to become a leading provider of antibodies and proteins to the research community.

Products and Services

EnCor Biotechnology offers a wide range of products and services, including:

• Monoclonal antibodies: These are antibodies that are made by identical immune cells that are all clones of a unique parent cell. They have monovalent affinity, in that they bind to the same epitope.

• Polyclonal antibodies: These are derived from different B cell lineages. They are usually a mix of different plasma cells.

• Recombinant proteins: These are proteins that are produced through recombinant DNA technology. This involves the introduction of a DNA sequence coding for a protein into a host organism, where it is then expressed and a protein is produced.

• Peptide synthesis: This is the production of peptides, which are short chains of amino acid monomers linked by peptide bonds.

• Custom antibody production: This is a service where the company produces antibodies to a specific antigen as per the customer's requirements.

Research and Development

EnCor Biotechnology is heavily involved in research and development, with a particular focus on neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. The company's research efforts are aimed at understanding the underlying mechanisms of these diseases and developing effective treatments.

See Also

• Biotechnology
• Neurodegenerative diseases
• Antibodies
• Proteins